Cargando…

Inflammatory Bowel Disease: Complexity and Variability Need Integration

Detalles Bibliográficos
Autor principal:	Fiocchi, Claudio
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2018
Materias:	Medicine
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5873363/ https://www.ncbi.nlm.nih.gov/pubmed/29619371 http://dx.doi.org/10.3389/fmed.2018.00075

Ejemplares similares

Inflammatory Bowel Disease Therapy: Beyond the Immunome
por: Fiocchi, Claudio, et al.
Publicado: (2022)

Inflammatory Bowel Disease: Autoimmune or Immune-mediated Pathogenesis?
por: Wen, Zhonghui, et al.
Publicado: (2004)

Editorial: Challenges in Inflammatory Bowel Disease: Current, Future and Unmet Needs
por: Gravina, Antonietta Gerarda, et al.
Publicado: (2022)

Angiocrine Regulation of Epithelial Barrier Integrity in Inflammatory Bowel Disease
por: Stürzl, Michael, et al.
Publicado: (2021)

Editorial: Challenges in inflammatory bowel disease: current, future and unmet needs, volume II
por: Gravina, Antonietta Gerarda, et al.
Publicado: (2023)

Prognostication in inflammatory bowel disease
por: Spencer, Elizabeth A., et al.
Publicado: (2022)

Innate Lymphoid Cells as Regulators of Epithelial Integrity: Therapeutic Implications for Inflammatory Bowel Diseases
por: Schulz-Kuhnt, Anja, et al.
Publicado: (2021)

Intestinal Epithelium in Inflammatory Bowel Disease
por: Coskun, Mehmet
Publicado: (2014)

Serum Biomarkers for Inflammatory Bowel Disease
por: Chen, Peng, et al.
Publicado: (2020)

Are Probiotics or Prebiotics Useful in Pediatric Irritable Bowel Syndrome or Inflammatory Bowel Disease?
por: Guandalini, Stefano
Publicado: (2014)

Innovative approaches to service integration addressing the unmet needs of irritable bowel syndrome patients and new approaches for the needs of IBS patients
por: Gentile, Maurizio, et al.
Publicado: (2022)

New Strategies for Treatment of Inflammatory Bowel Disease
por: Nielsen, Ole Haagen
Publicado: (2014)

Predicting Response to Vedolizumab in Inflammatory Bowel Disease
por: Meserve, Joseph, et al.
Publicado: (2020)

Co-pathogens in Periodontitis and Inflammatory Bowel Disease
por: Cai, Zhengwen, et al.
Publicado: (2021)

Editorial: Game Changers in Inflammatory Bowel Diseases
por: Bálint, Anita, et al.
Publicado: (2021)

Disease-Specific Enteric Microbiome Dysbiosis in Inflammatory Bowel Disease
por: Mirsepasi-Lauridsen, Hengameh Chloé, et al.
Publicado: (2018)

Personalize, participate, predict, and prevent: 4Ps in inflammatory bowel disease
por: Lenti, Marco Vincenzo, et al.
Publicado: (2023)

Managing Psoriatic Arthritis With Inflammatory Bowel Disease and/or Uveitis
por: Chia, Alfred Yu Ting, et al.
Publicado: (2021)

Risk of Inflammatory Bowel Disease Following Appendectomy in Adulthood
por: Chung, Wei-Sheng, et al.
Publicado: (2021)

Treatment of Inflammatory Bowel Disease: A Comprehensive Review
por: Cai, Zhaobei, et al.
Publicado: (2021)

Technological advances in inflammatory bowel disease endoscopy and histology
por: Alfarone, Ludovico, et al.
Publicado: (2022)

Unmet needs in inflammatory bowel disease
por: Revés, Joana, et al.
Publicado: (2021)

Epidemiology of Inflammatory Bowel Diseases in Nepal
por: Paudel, Mukesh S, et al.
Publicado: (2021)

Ocular Manifestations of Inflammatory Bowel Disease
por: Licona Vera, Erik, et al.
Publicado: (2023)

Biomarkers Predictive of Response to Thiopurine Therapy in Inflammatory Bowel Disease
por: Cornish, Jack S., et al.
Publicado: (2020)

Tailoring Biologic or Immunomodulator Treatment Withdrawal in Inflammatory Bowel Disease
por: Louis, Edouard
Publicado: (2020)

Intestinal Organoids as a Tool for Inflammatory Bowel Disease Research
por: Angus, Hamish C. K., et al.
Publicado: (2020)

Rules of Engagement: Epithelial-Microbe Interactions and Inflammatory Bowel Disease
por: Jergens, Albert E., et al.
Publicado: (2021)

The Role and Function of Mucins and Its Relationship to Inflammatory Bowel Disease
por: Kang, Youra, et al.
Publicado: (2022)

Multi-utility of therapeutic drug monitoring in inflammatory bowel diseases
por: Martins, Camilla de Almeida, et al.
Publicado: (2022)

Urinary chemerin as a potential biomarker for inflammatory bowel disease
por: Gunawan, Stefan, et al.
Publicado: (2022)

Editorial: Game changers in inflammatory bowel diseases, volume II
por: Lovász, Barbara Dorottya, et al.
Publicado: (2023)

Extra-Intestinal Manifestations of Inflammatory Bowel Disease
por: Sange, Aliya H, et al.
Publicado: (2021)

Future of Endoscopy in Inflammatory Bowel Diseases (IBDs)
por: Agrawal, Laksh S, et al.
Publicado: (2022)

Emerging Mechanisms of Innate Immunity and Their Translational Potential in Inflammatory Bowel Disease
por: Corridoni, Daniele, et al.
Publicado: (2018)

Can We Predict the Toxicity and Response to Thiopurines in Inflammatory Bowel Diseases?
por: Luber, Raphael P., et al.
Publicado: (2019)

Exploring Links Between Industrialization, Urbanization, and Chinese Inflammatory Bowel Disease
por: Cui, Guanglin, et al.
Publicado: (2021)

Thiopurines in Inflammatory Bowel Disease. How to Optimize Thiopurines in the Biologic Era?
por: Gargallo-Puyuelo, Carla J., et al.
Publicado: (2021)

Endoscopic Surveillance in Inflammatory Bowel Diseases: Selecting a Suitable Technology
por: Dal Buono, Arianna, et al.
Publicado: (2022)

Hot topics on fecal microbiota transplantation for the treatment of inflammatory bowel disease
por: Zhang, Xiaochen, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_oal4a8a1khecqe5lmv945b1ltv